Alpine Immune Sciences Announces Inducement Grant to Andrew S. Sandler, M.D. Under Nasdaq Listing Rule 5635(c)

as Chief Medical Officer, it has granted Dr. Sandler an option to purchase 160,000 shares of common stock.